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Background and objective: 
Evidence indicates that migration to Western countries is associated with increased metabolic syndrome (MetS) risk. There is, however, a scarcity of data about MetS incidence in migrants to Middle Eastern 
countries. This study aimed to investigate the relationship between migration and the incidence of MetS following a 24-months residency in Qatar.
Methods:
Following the necessary ethics approvals, migrants to Qatar aged 18 – 65 years were invited to participate. Baseline screening for MetS parameters included glycated haemoglobin, triglycerides, high-density 
lipoproteincholesterol, blood pressure, and waist circumference. Migrants with normal metabolic parameters were invited for rescreening 24-months post-migration and, parameters repeated. Those with 
abnormal metabolic parameters were counselled or referred for medical review and excluded from follow up.
Figure 1: Flow diagram of  participant recruitment 
during period one 
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Figure 2 : Flow diagram of  participant follow up during period 
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Migrants had follow up lab investigations: FBG, 
TG and HDL-C, measurements; BP & waist 
circumference, along with the WHO STEPWISE 
questionnaire (3)
Were offered relevant 
healthcare referral
MetS-free migrants identified through period 
one and fulfilling the study criteria were 




MetS as per IDF 
criteria (2)
Participants 
with 1 or 2 
MetS criteria
Conclusion
Migration to Qatar was associated with the development of MetS after 24 months of 
migration. Further studies are required to determine the risk factors and the predictors of 
MetS amongst migrants to Qatar.
Given the cultural similarities and importance of migration in Qatar and other Middle-Eastern 




472 consented to participate
205 with normal metabolic 
parameters were followed up  
24 months post migration
The incidence of MetS within this group 
with normal parameters rose to 17% 
(n=27). 
81% (n=129) developed at least one 
element of MetS. 
Migrants receiving medications that potentially induce MetS 
were more likely to develop MetS (odd ratio [OR], 4.7; 95% 
confidence interval [CI], 0.07-0.59. p=0.003).
6X 
RESULTS
At the follow up (24 months post migration)
Migrants attended the pre-employment 
medical check-up at HMC pre-
employment/staff  clinic
One or more 
MetS criteria 
Healthy
MetS as per IDF 
criteria (2)
Were included 






The incidence of metabolic syndrome amongst initially metabolic syndrome-free migrants, 24-months post migration. 
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 There is substantial evidence that 
migration to Western countries is 
associated with increased risk of 
Metabolic syndrome (MetS)*
 However, there is paucity of data about 
incidence of new-onset MetS in migrants 
from different countries to Qatar and the 
Middle East. 
 As a result, an important health problem 
is overlooked, and prevention measures 
are absent. 
* (1) Bharmal N, Kaplan RM, Shapiro MF, Mangione CM, Kagawa-
Singer M, Wong MD, et al. The association of duration of residence in 
the United States with cardiovascular disease risk factors among 





Nationals to migrants' proportion in the 




 The aim of this study was to investigate the 
relationship between migration and the 
incidence of MetS following 24-months 
residency in Qatar and identify possible 
MetS determinants.
Baseline screening
• Migrants aged 18 – 65 
years employed at HMC 
were invited to consent 
and participate. 
Following the consent
• Baseline screening for MetS was 
conducted
• Parameters included glycated 
hemoglobin (HbA1c), 
triglycerides (TG), high-density 
lipoprotein-cholesterol (HDL-C), 




A group of HMC 
employees 
Recently migrated to 
Qatar 
Have been living in 













Throughout the study, migrants with 
metabolic abnormalities were referred to 
physicians for further management. 

1084 migrants contacted
472 consented to participate
205 with normal metabolic 
parameters were followed 
up  24 months post migration
The incidence of MetS within this 
group with normal parameters rose 
to 17% (n=27). 
81% (n=129) developed at least one 
element of MetS. 
Migrants receiving medications that 
potentially induce MetS were more 
likely to develop MetS (Adjusted OR 
6.3, 95% CI; 2.27-17.73, p<0.001).
6 X 
At the follow up (24 months post migration)
Migrants to Qatar, 
were at increased 
MetS incidence 
during 24-months of 
migration
Administration of 
medications that can 
induce MetS 
increased the risk of 
MetS amongst 
migrants by more 
than six-fold. 
This study will guide 
policymakers within 
the Ministry of Public 
Health and HMC in 
implementing 
preventative 




for early warning 
systems.
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